Symbol
| DNM2
| contributors: mct/shn - updated : 28-11-2018
|
HGNC name
| dynamin 2
|
HGNC id
| 2974
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --low
|  
|
in late-onset Alzheimer disease, results in the accumulation of APP in lipid raft-rich plasma membranes | tumoral
|  
|  
| --over
|  
|
is associated with IKAROS dysregulation and may be important in the development of B- Acute Lymphoblastic Leukemia | constitutional
|  
|  
| --low
|  
|
coupled with severe ventricular arrhythmias | |
Susceptibility
|
to late-onset Alzheimer disease (LOAD) |
Variant & Polymorphism
other
| polymorphisms increasing the risk of late-onset Alzheimer disease (LOAD) |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cardiovascular | rythm | | |
with its multi-ion channel targeting properties, could be a promising target for novel antiarrhythmic therapies |
| | | |
| in isolated muscle fibers from wild-type and HTZ mice, Dnm2 localized in regions of intense membrane trafficking (I-band and perinuclear region), emphasizing the pathophysiological hypothesis in which Dnm2-dependent trafficking would be altered |